Clinical Trial Update: Treatment of AD With IgE Specific Immunoadsorption (IGEIAAD) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating IgE-specific immunoadsorption for treating atopic dermatitis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• IgE-specific immunoadsorption (IGEIAAD) (IgE immunoadsorption)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Atopic Dermatitis | Phase 2 | Status: RECRUITING